Scholarly Index
Michael Charlton
Madrigal Pharmaceuticals (United States); 40,641 total citations; 355 total publications; best world rank #46
Madrigal Pharmaceuticals (United States)
40,641Total citations
355Total publications
91H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Liver Disease Diagnosis and Treatment | Lifetime | 100 | US 37 | 99.81 |
| Liver Disease and Transplantation | Lifetime | 46 | US 18 | 99.78 |
| Hepatitis C virus research | Lifetime | 87 | US 33 | 99.68 |
| Organ Transplantation Techniques and Outcomes | Lifetime | 184 | US 86 | 99.31 |
| Hepatitis B Virus Studies | Lifetime | 264 | US 95 | 99.22 |
| Diet, Metabolism, and Disease | Lifetime | 195 | US 85 | 98.83 |
| Liver Diseases and Immunity | Lifetime | 160 | US 51 | 98.55 |
| Renal Transplantation Outcomes and Treatments | Lifetime | 384 | US 206 | 98.39 |
| Alcohol Consumption and Health Effects | Lifetime | 366 | US 184 | 97.34 |
| Lipid metabolism and disorders | Lifetime | 699 | US 253 | 93.36 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 618 | US 139 | 97.25 |
| Liver Disease and Transplantation | 2021-2025 | 380 | US 109 | 96.26 |
| Liver Diseases and Immunity | 2021-2025 | 143 | US 39 | 94.47 |
| Organ Transplantation Techniques and Outcomes | 2021-2025 | 548 | US 221 | 92.63 |
| Diet, Metabolism, and Disease | 2021-2025 | 427 | US 84 | 89.80 |